Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice
about
Comparison of echinocandin antifungalsEchinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infectionMicafungin.Prevention of infection caused by Pneumocystis carinii in transplant recipients.Efficacy of micafungin alone or in combination against systemic murine aspergillosis.The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.New and emerging antifungal agents: impact on respiratory infections.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Colonization by Pneumocystis jirovecii and its role in disease.Micafungin: pharmacology, experimental therapeutics and clinical applications.Echinocandin antifungals: review and update.The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.The use of caspofungin in HIV-infected individuals.Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.A clinical review of echinocandins in pediatric patients.Echinocandins in antifungal pharmacotherapy.Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.New agents for the treatment of systemic fungal infections--current status.
P2860
Q28273738-6E5623C0-E9ED-44AD-9980-61AE4A9C7B84Q28472713-690FD710-A1D7-4CC8-B11C-A85C097ACA97Q33981019-3588B546-917B-41DA-A960-64CF14BE6DE1Q34374874-A53AFFB0-708D-4D0D-8350-49792F44CF2EQ34884594-8CD97ECC-7D5C-4686-A349-791DDD16E44DQ35185757-064F40F4-8632-47FF-B0CA-700C12634DF1Q35627629-C18C74BB-9801-4114-B5CA-0EDA968D0220Q35920640-DE5B90D9-A49B-4CD5-90B4-ACA3E008FEA6Q35940586-CBFC7574-706F-4F0B-820A-01A2EDED9C76Q36120798-CB519480-CCA2-49F3-A830-C36CA06F99F5Q36441524-5A0E85DE-519B-4F93-90EA-82C92426E175Q36626518-E1895258-12F0-4395-B154-11630A61ED1AQ36821383-9F6DA29B-8F5E-42D9-AE9C-191A33D8CA19Q36895679-603E70AF-D090-4E3B-B777-5C51E0BFE4DDQ37653647-B741A45F-6A61-479B-9774-AB5B56B88245Q39458862-9999E9AD-CF2F-4433-9680-FA320F6EB68DQ40559190-0DEBF854-F515-469E-BA43-E682BEEEA192Q46576615-B0B0DC18-C698-4E65-840E-66CCF7E55206
P2860
Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prophylactic effect of FK463, ...... stis carinii infection in mice
@ast
Prophylactic effect of FK463, ...... stis carinii infection in mice
@en
Prophylactic effect of FK463, ...... stis carinii infection in mice
@nl
type
label
Prophylactic effect of FK463, ...... stis carinii infection in mice
@ast
Prophylactic effect of FK463, ...... stis carinii infection in mice
@en
Prophylactic effect of FK463, ...... stis carinii infection in mice
@nl
prefLabel
Prophylactic effect of FK463, ...... stis carinii infection in mice
@ast
Prophylactic effect of FK463, ...... stis carinii infection in mice
@en
Prophylactic effect of FK463, ...... stis carinii infection in mice
@nl
P2093
P2860
P1476
Prophylactic effect of FK463, ...... stis carinii infection in mice
@en
P2093
T Kuramochi
P2860
P304
P356
10.1128/AAC.44.9.2259-2262.2000
P407
P577
2000-09-01T00:00:00Z